These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25248754)

  • 41. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy.
    Moon JC; Reed E; Sheppard MN; Elkington AG; Ho SY; Burke M; Petrou M; Pennell DJ
    J Am Coll Cardiol; 2004 Jun; 43(12):2260-4. PubMed ID: 15193690
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of cardiovascular magnetic resonance in sudden death risk stratification in hypertrophic cardiomyopathy.
    Maron MS
    Card Electrophysiol Clin; 2015 Jun; 7(2):187-93. PubMed ID: 26002385
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic Value of LGE-CMR in HCM: A Meta-Analysis.
    Weng Z; Yao J; Chan RH; He J; Yang X; Zhou Y; He Y
    JACC Cardiovasc Imaging; 2016 Dec; 9(12):1392-1402. PubMed ID: 27450876
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.
    Yin L; Xu HY; Zheng SS; Zhu Y; Xiao JX; Zhou W; Yu SS; Gong LG
    Int J Cardiovasc Imaging; 2017 Dec; 33(12):1949-1959. PubMed ID: 28612277
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.
    Wu LM; Chen BH; Yao QY; Ou YR; Wu R; Jiang M; Hu J; An DA; Xu JR
    Int J Cardiovasc Imaging; 2016 Aug; 32(8):1289-97. PubMed ID: 27198892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Teraoka K
    Magn Reson Imaging; 2005 Jun; 23(5):701. PubMed ID: 16051047
    [No Abstract]   [Full Text] [Related]  

  • 47. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy.
    Dimitrow PP
    Magn Reson Imaging; 2004 Nov; 22(9):1339. PubMed ID: 15607110
    [No Abstract]   [Full Text] [Related]  

  • 48. Texture analysis and machine learning of non-contrast T1-weighted MR images in patients with hypertrophic cardiomyopathy-Preliminary results.
    Baeßler B; Mannil M; Maintz D; Alkadhi H; Manka R
    Eur J Radiol; 2018 May; 102():61-67. PubMed ID: 29685546
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myocardial fibrosis in hypertrophic cardiomyopathy: accurate reflection of histopathological findings by CMR.
    Moravsky G; Ofek E; Rakowski H; Butany J; Williams L; Ralph-Edwards A; Wintersperger BJ; Crean A
    JACC Cardiovasc Imaging; 2013 May; 6(5):587-96. PubMed ID: 23582356
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging.
    Bogaert J; Goldstein M; Tannouri F; Golzarian J; Dymarkowski S
    AJR Am J Roentgenol; 2003 Apr; 180(4):981-5. PubMed ID: 12646440
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cardiac magnetic resonance imaging and sudden death risk in patients with hypertrophic cardiomyopathy.
    McKenna WJ; Nagueh SF
    Circulation; 2014 Aug; 130(6):455-7. PubMed ID: 25092277
    [No Abstract]   [Full Text] [Related]  

  • 52. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
    Appelbaum E; Maron BJ; Adabag S; Hauser TH; Lesser JR; Haas TS; Riley AB; Harrigan CJ; Delling FN; Udelson JE; Gibson CM; Manning WJ; Maron MS
    Circ Cardiovasc Imaging; 2012 Jan; 5(1):78-85. PubMed ID: 22135401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Myocardial scar as arrhythmia risk in patients with hypertrophic cardiomyopathy.
    Amado LC; Lima JA
    Curr Opin Cardiol; 2010 May; 25(3):276-81. PubMed ID: 20224393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy.
    Hussain T; Dragulescu A; Benson L; Yoo SJ; Meng H; Windram J; Wong D; Greiser A; Friedberg M; Mertens L; Seed M; Redington A; Grosse-Wortmann L
    Pediatr Cardiol; 2015 Jun; 36(5):970-8. PubMed ID: 25605038
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum Matrix Metalloproteinases as Quantitative Biomarkers for Myocardial Fibrosis and Sudden Cardiac Death Risk Stratification in Patients With Hypertrophic Cardiomyopathy.
    Münch J; Avanesov M; Bannas P; Säring D; Krämer E; Mearini G; Carrier L; Suling A; Lund G; Patten M
    J Card Fail; 2016 Oct; 22(10):845-50. PubMed ID: 27018569
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [What is late gadolinium enhancement in hypertrophic cardiomyopathy?].
    Moon JC
    Rev Esp Cardiol; 2007 Jan; 60(1):1-4. PubMed ID: 17288947
    [No Abstract]   [Full Text] [Related]  

  • 60. Case 153: atypical tumefactive hypertrophic cardiomyopathy.
    Dillman JR; Mueller GC; Attili AK; Dorfman AL; Ensing GJ; Gordon D
    Radiology; 2010 Jan; 254(1):310-3. PubMed ID: 20032162
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.